Target intelligence / Profile preview

Herpes simplex virus infected cell protein 0 (ICP0)

Target
ICP0
Molecular classification
Viral protein, E3 ubiquitin ligase (RING-finger containing), Transcriptional activator, Immediate-early (α) gene product
01

Overview

Infected cell protein 0 (ICP0) is a herpes simplex virus-encoded immediate-early protein that acts as a promiscuous transactivator to stimulate the transcription of viral genes, and is critical for efficient viral replication[1][4][6][7]. ICP0 localizes initially to the nucleus where it disrupts ND10 and PML nuclear bodies, mediates the degradation of restriction factors through its E3 ubiquitin ligase activity, and modulates cellular transcription factor complexes including CoREST and BMAL1[5][6][7]. These mechanisms allow the virus to evade host immune responses and promote gene expression necessary for viral growth. ICP0 is a target for novel antivirals aiming to prevent herpesvirus replication by inhibiting its ubiquitin ligase function or its transcriptional activation capacity[3]. The gene and protein have been well characterized in HSV-1 and are considered central to the virus’s strategy for host cell takeover and immune evasion[1][3][4][6].

Other names
Infected Cell Protein 0IE110Immediate Early Gene 1HSV-1 α0
02

Mechanism of action

Inhibition of E3 ubiquitin ligase activity (blocks ICP0-mediated degradation of host proteins that restrict viral replication); Stabilization of PML bodies or host restriction factors (prevents ICP0 effects on immune system and viral replication)

03

Biological functions

Promotes viral gene transcription (transactivator)Disrupts promyelocytic leukemia (PML) nuclear bodies and ND10 domains in host cell nucleusMediates ubiquitination and degradation of host antiviral proteins (including PML, Sp100, and others)Inactivates intrinsic and innate immune defenses (e.g., IFN-mediated responses)Modifies host chromatin and transcriptional regulatory complexes
04

Disease associations

Infection (involved in herpes simplex virus infection and replication)Immune evasionPotential involvement in inflammation and cancer due to ability to disrupt cellular regulatory pathways
05

Safety considerations

Targeting ICP0 must be selective for infected cells to avoid off-target effects on host ubiquitin pathwaysICP0 manipulates broad host transcriptional programs, raising risks for unintended cellular consequences
06

Interacting drugs

No directly approved ICP0-specific drugs as of 2024

1 more in the full profile.

07

Biomarkers

Levels of ICP0 protein expression in infected cells (may be used in research or candidate diagnostic markers for HSV-1 activity)Host cell markers: Dispersal of PML nuclear bodies and altered ubiquitination signatures may indicate ICP0 activity

Beyond the preview

Go deeper on Herpes simplex virus infected cell protein 0 (ICP0).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpes simplex virus infected cell protein 0 (ICP0).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call